Literature DB >> 23659532

Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates.

J Michael Soucie, Paul E Monahan, Roshni Kulkarni, Christine De Staercke, Michael Recht, Meera B Chitlur, Ralph Gruppo, W Craig Hooper, Craig Kessler, Marilyn J Manco-Johnson, Jerry Powell, Meredith Pyle, Brenda Riske, Hernan Sabio, Sean Trimble.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23659532     DOI： 10.1111/trf.12153

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  4 in total

Review 1.  Clinical use of factor VIII and factor IX concentrates.

Authors:  Massimo Morfini; Antonio Coppola; Massimo Franchini; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 2.  Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Gabriele Calizzani; Fabio Candura; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

3.  Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives.

Authors:  Junting Jia; Yuyuan Ma; Xiong Zhao; Yi Guo; Chaoji Huangfu; Chi Fang; Rui Fan; Maomin Lv; Huiqiong Yin; Jingang Zhang
Journal:  Virol J       Date:  2015-10-06       Impact factor: 4.099

Review 4.  Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders.

Authors:  Giovanni Di Minno; Carlo Federico Perno; Andreas Tiede; David Navarro; Mariana Canaro; Lutz Güertler; James W Ironside
Journal:  Blood Rev       Date:  2015-07-20       Impact factor: 8.250
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.